📈Proposed Rule Change for Selective Midpoint Order by NYSE Arca
The Securities and Exchange Commission is reviewing a proposed rule change by NYSE Arca to implement the Selective Midpoint Order (SeMi), which will replace the Discretionary Pegged Order. This new order type aims to enhance market liquidity and prevent trades during unstable conditions, utilizing a machine learning model for market stability predictions.
Learn More💊FDA Determines RIOMET Not Withdrawn, Impacts Drug Approvals
The Food and Drug Administration (FDA or Agency) has determined that RIOMET (metformin hydrochloride) Oral Solution, 500 milligrams (mg)/5 milliliters (mL) has not been withdrawn from sale for reasons of safety or effectiveness. This determination means that FDA will not begin procedures to withdraw approval of abbreviated new drug applications (ANDAs) that refer to this drug product, and it will allow FDA to continue to approve ANDAs that refer to the product as long as they meet relevant legal and regulatory requirements.
Learn More📈Nasdaq Proposes Trading Halt for Launch Day of Exchange-Traded Products
The Nasdaq Stock Market proposes a regulatory change allowing an optional trading halt for Exchange-Traded Products (ETPs) on their first day of trading. This mechanism aims to improve price discovery and manage volatility similar to existing IPO procedures, benefiting both issuers and investors.
Learn More